US 9314477
Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof
granted A61KA61K31/395A61K31/435
Quick answer
US patent 9314477 (Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof) held by RedHill Biopharma Ltd. expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/395, A61K31/435, A61K31/438, A61K31/44